Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Healthcare Professionals
Investors & Media
Shares
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Healthcare Professionals
Investors & Media
Shares
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Contact Us
Career
News
IBT has relocated to a new office
October 1, 2015
Come visit us at our new office at Bryggargatan 10, 111 21 Stockholm, Sweden.
Latest press releases
2026-04-02 09:15
Correction: Notice of Annual General Meeting of Infant Bacterial Therapeutics
Regulatory
2026-03-30 14:30
Notice of Annual General Meeting of Infant Bacterial Therapeutics
Regulatory
2026-03-27 07:30
Infant Bacterial Therapeutics AB publishes the Annual Report for 2025
Regulatory
2026-03-03 07:00
Infant Bacterial Therapeutics (IBT) publishes results from ”The Connection Study” in Pediatric Research
2026-02-06 07:30
Infant Bacterial Therapeutics AB (publ) Year-end-report January 1 – December 31, 2025
Regulatory